These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18457627)

  • 1. [Needs of cost-effectivity analysis for the optimization and rationalization of expense in new drugs].
    Soto Alvarez J
    Med Clin (Barc); 2008 Apr; 130(14):559. PubMed ID: 18457627
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-related morbidity and mortality: an economic and clinical perspective.
    Bootman JL
    Manag Care; 2002 Feb; 11(2 Suppl):12-5. PubMed ID: 11907995
    [No Abstract]   [Full Text] [Related]  

  • 3. Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS.
    Lichtenberg FR
    Health Aff (Millwood); 2001; 20(5):241-51. PubMed ID: 11558710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survey of health services; economics in Spain].
    López Zumel JM
    Nueva Enferm; 1980 Apr; (10):5-6. PubMed ID: 6782521
    [No Abstract]   [Full Text] [Related]  

  • 5. [Technical discussions at the 20th Panamerican Health Conference. Repercussions of the cost of drugs on the cost of health: national and international problems].
    Bol Oficina Sanit Panam; 1979 Dec; 87(6):471-93. PubMed ID: 161718
    [No Abstract]   [Full Text] [Related]  

  • 6. [The association between mortality and the cost of medications persists even controlling for per capita income].
    Porta Serra M; Kritchevsky SB
    Gac Sanit; 1987; 1(1):5-11. PubMed ID: 3148569
    [No Abstract]   [Full Text] [Related]  

  • 7. Focus on drugs.
    Vail S
    Can Nurse; 1996 Jan; 92(1):60, 59. PubMed ID: 8920559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-effectiveness analysis of drugs].
    Internist (Berl); 1994 May; 35(5 Kosten-nutzen):1-8. PubMed ID: 9532229
    [No Abstract]   [Full Text] [Related]  

  • 9. Substantial treatment overuse in the United States?
    Gandjour A
    Value Health; 2007; 10(3):221; author reply 222. PubMed ID: 17532815
    [No Abstract]   [Full Text] [Related]  

  • 10. How pharmaceuticals cut direct & indirect costs of therapy.
    Levy RA
    Pharm Times; 1985 Dec; 51(12):82-8. PubMed ID: 10311420
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacoeconomic factors in the treatment of acute hypertension.
    Shulkin DJ
    Hosp Formul; 1994 Aug; 29 Suppl 2():S15-20. PubMed ID: 10135742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counting the cost of care.
    Mooney G
    Nurs Stand; 1988 Aug; 2(45):28-9. PubMed ID: 3137481
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-cost therapeutic agents. Uses and abuses.
    Bunker JP
    Int J Technol Assess Health Care; 1997; 13(4):521-5. PubMed ID: 9489244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of health care.
    Aspaas PK
    S D Med; 2006 Nov; 59(11):462. PubMed ID: 17180840
    [No Abstract]   [Full Text] [Related]  

  • 15. Are drugs too expensive in Canada? Yes.
    Lexchin J
    Can Fam Physician; 2006 May; 52(5):573-6, 578-81. PubMed ID: 16739821
    [No Abstract]   [Full Text] [Related]  

  • 16. When drugs are worth more than gold!
    Schwartsmann G; Picon PD
    Lancet Oncol; 2007 Dec; 8(12):1049-1050. PubMed ID: 18054873
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of newer drugs on health spending: do they really increase the costs?
    Civan A; Köksal B
    Health Econ; 2010 May; 19(5):581-95. PubMed ID: 19404925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How effective is health coaching in reducing health services expenditures?
    Jonk Y; Lawson K; O'Connor H; Riise KS; Eisenberg D; Dowd B; Kreitzer MJ
    Med Care; 2015 Feb; 53(2):133-40. PubMed ID: 25588134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical expenditure in Spain: cost and control.
    Lopez Bastida J; Mossialos E
    Int J Health Serv; 2000; 30(3):597-616. PubMed ID: 11109184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical expenditure and therapeutic value of new medicines in Spain.
    Darba J
    Pharmacoeconomics; 2003; 21(16):1211-2. PubMed ID: 14594440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.